Hemodynamic effects of a low versus a high dose of propofol during induction of anesthesia. A randomized trial
Acta Anaesthesiologica Scandinavica · 2023
DOI: 10.1111/aas.14293 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2023. Verfasst von Gunnar Helge Sjøen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Haugesund Hospital, Haugesund, Norway. Hauptthemen laut MEDLINE: Propofol, Hypotension. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hypotension is common after anesthesia induction with propofol and is associated with increased morbidity. It is important to examine the effects of the proposed interventions to limit preventable hypotension, as suggested by the reduction in the dose of propofol. Our objective was to investigate whether a high dose of propofol is inferior to a low dose with respect to changes in systolic arterial blood pressure (SAP).
Methods
This randomized, double‐blind, dose‐controlled, non‐inferiority study included 68 healthy women scheduled for gynecological surgery at the Day Surgery Unit, Haugesund Hospital, Norway. The patients were randomly allocated 1:1 to a low or high dose (1.4 mg/kg total body weight (TBW) versus 2.7 mg/kg TBW of propofol corresponding to maximal effect site concentrations (Ce) of 2.0 μg/mL versus 4.0 μg/mL. The dose of remifentanil was 1.9–2.0 μg/kg TBW, with maximal Ce of 5.0 ng/mL. The patients were observed for 450 s from the start of the infusions. The first 150 s was the sedation period, after which a bolus of propofol and remifentanil was administered. Baseline was defined as 55–5 s before the bolus doses. LiDCOplus was used for invasive beat‐to‐beat hemodynamic monitoring of changes in SAP, heart rate (HR), cardiac output (CO), stroke volume (SV), and systemic vascular resistance (SVR). A difference of 10 mmHg in the change in SAP was considered to be clinically important.
Results
The SAP change difference for low versus high dose was −2.9 mmHg (95% CI −9.0–3.1). The relative changes for low versus high dose were SAP −31% versus −36%, ( p < .01); HR −24% versus −20%, ( p = .09); SVR −20% versus −31%, ( p < .001); SV −16% versus −20%, ( p = .04); and CO −35% versus −32%, ( p = .33).
Conclusion
A high dose of propofol was not inferior to a low dose, and a reduction in the dose of propofol did not result in clinically important attenuation of major hemodynamic changes during induction in healthy women. Trial Registration ClinicalTrials.gov identifier NCT 03861364, January 3, 2019.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Haugesund Hospital, Haugesund, Norway.
- Department of Research and Innovation, Haugesund, Norway.
- Faculty of Medicine, University of Oslo, Oslo, Norway.
- Oslo Centre for Epidemiology and Biostatistics, Research Support Services, Oslo University Hospital, Oslo, Norway.
- Norwegian Ministry of Trade, Industry and Fisheries, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Zitieren
APA
Sjøen, G. H., Falk, R. S., Hauge, T. H., Tønnessen, T. I., & Langesaeter, E. (2023). Hemodynamic effects of a low versus a high dose of propofol during induction of anesthesia. A randomized trial. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14293
Vancouver
Sjøen GH, Falk RS, Hauge TH, Tønnessen TI, Langesaeter E. Hemodynamic effects of a low versus a high dose of propofol during induction of anesthesia. A randomized trial. Acta Anaesthesiologica Scandinavica. 2023. doi:10.1111/aas.14293
BibTeX
@article{Sjen2023,
author = {Sjøen, Gunnar Helge and Falk, Ragnhild Sørum and Hauge, Tor Hugo and Tønnessen, Tor Inge and Langesaeter, Eldrid},
title = {Hemodynamic effects of a low versus a high dose of propofol during induction of anesthesia. A randomized trial},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2023},
doi = {10.1111/aas.14293}
}
EUVIMED